Matches in Wikidata for { <http://www.wikidata.org/entity/Q88887003> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q88887003 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88887003 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88887003 description "scientific article published on 28 May 2018" @default.
- Q88887003 description "wetenschappelijk artikel" @default.
- Q88887003 description "наукова стаття, опублікована в травні 2018" @default.
- Q88887003 name "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 name "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 type Item @default.
- Q88887003 label "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 label "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 prefLabel "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 prefLabel "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 P1433 Q88887003-BFC3B3DE-7F5C-4173-B9D3-A0C680F519E3 @default.
- Q88887003 P1476 Q88887003-A59D3094-3CA8-4E36-9C8F-12489675A92E @default.
- Q88887003 P2093 Q88887003-E4C40AAF-FFA4-4F2F-A1C5-7BEAE877FCBE @default.
- Q88887003 P2860 Q88887003-11D771CD-82B3-48DA-91FE-03043BB3F887 @default.
- Q88887003 P2860 Q88887003-40FB6176-9233-484D-B6F8-985EE382264B @default.
- Q88887003 P2860 Q88887003-48C80F78-3EC0-4F83-BCAF-366B52D2D421 @default.
- Q88887003 P2860 Q88887003-B5BDAE28-A0D0-405C-8E78-7B03AD6B98C9 @default.
- Q88887003 P2860 Q88887003-B9FD0568-ED53-4CC1-ACDC-EE9FACD3A701 @default.
- Q88887003 P2860 Q88887003-C1744F04-3791-4DDF-93E2-348CCD2FED83 @default.
- Q88887003 P2860 Q88887003-CE86DF2D-C917-4FFB-B2F7-ED21BFA47182 @default.
- Q88887003 P2860 Q88887003-DE51FE51-E066-4051-BA50-96B5DC22457A @default.
- Q88887003 P2860 Q88887003-E13414DD-C35F-47B1-BB5B-713F38990D01 @default.
- Q88887003 P2860 Q88887003-E13F5211-4497-4AE3-9600-A5E5DDD5403F @default.
- Q88887003 P2860 Q88887003-ECDC1B7B-7689-4AB5-BEAC-88ADF1861379 @default.
- Q88887003 P304 Q88887003-E26FAB7B-8F09-4329-BC78-E6519A7CCE40 @default.
- Q88887003 P31 Q88887003-2C742015-5B42-4478-B5B7-241F2CDE9A0A @default.
- Q88887003 P356 Q88887003-CA13ABF1-AB60-429E-93C0-135440C98E22 @default.
- Q88887003 P433 Q88887003-DC2FC9E7-2D22-4CC1-ABE0-E749C39EC000 @default.
- Q88887003 P478 Q88887003-CFF5EC31-6072-46D4-8C21-A330BA7F6BF0 @default.
- Q88887003 P50 Q88887003-560E640D-EDC2-4341-888B-E773F234065D @default.
- Q88887003 P577 Q88887003-84593A2E-BE85-408F-B068-2BE5209D7626 @default.
- Q88887003 P698 Q88887003-9251C2A2-E2EB-4046-B202-B864D00B2755 @default.
- Q88887003 P921 Q88887003-DA84A9E2-A458-4F9A-AB24-7D1D1EBFAFC6 @default.
- Q88887003 P921 Q88887003-E1898457-6A4C-4FFE-B973-CB51607FF26C @default.
- Q88887003 P356 S11255-018-1896-8 @default.
- Q88887003 P698 29808447 @default.
- Q88887003 P1433 Q15763616 @default.
- Q88887003 P1476 "Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?" @default.
- Q88887003 P2093 "Carlos G Musso" @default.
- Q88887003 P2860 Q33381183 @default.
- Q88887003 P2860 Q35618793 @default.
- Q88887003 P2860 Q36244981 @default.
- Q88887003 P2860 Q37673264 @default.
- Q88887003 P2860 Q39251479 @default.
- Q88887003 P2860 Q42113690 @default.
- Q88887003 P2860 Q47195972 @default.
- Q88887003 P2860 Q48310133 @default.
- Q88887003 P2860 Q50998724 @default.
- Q88887003 P2860 Q51252547 @default.
- Q88887003 P2860 Q72396297 @default.
- Q88887003 P304 "1365-1366" @default.
- Q88887003 P31 Q13442814 @default.
- Q88887003 P356 "10.1007/S11255-018-1896-8" @default.
- Q88887003 P433 "7" @default.
- Q88887003 P478 "50" @default.
- Q88887003 P50 Q88887001 @default.
- Q88887003 P577 "2018-05-28T00:00:00Z" @default.
- Q88887003 P698 "29808447" @default.
- Q88887003 P921 Q17165460 @default.
- Q88887003 P921 Q41333323 @default.